0001123292-21-001446.txt : 20211115
0001123292-21-001446.hdr.sgml : 20211115
20211115162442
ACCESSION NUMBER: 0001123292-21-001446
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211115
FILED AS OF DATE: 20211115
DATE AS OF CHANGE: 20211115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Prime Movers Lab Fund I LP
CENTRAL INDEX KEY: 0001751631
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41058
FILM NUMBER: 211411102
BUSINESS ADDRESS:
STREET 1: PO BOX 12829
CITY: JACKSON
STATE: WY
ZIP: 83002
BUSINESS PHONE: 3072035036
MAIL ADDRESS:
STREET 1: PO BOX 12829
CITY: JACKSON
STATE: WY
ZIP: 83002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sloss Dakin
CENTRAL INDEX KEY: 0001875411
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41058
FILM NUMBER: 211411101
MAIL ADDRESS:
STREET 1: 126 E 56TH ST, 30TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxxinity, Inc.
CENTRAL INDEX KEY: 0001851657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862083865
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1717 MAIN STREET
STREET 2: SUITE 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: (254) 244-5739
MAIL ADDRESS:
STREET 1: 1717 MAIN STREET
STREET 2: SUITE 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-11-15
0001851657
Vaxxinity, Inc.
VAXX
0001751631
Prime Movers Lab Fund I LP
P.O. BOX 12829
JACKSON
WY
83002
0
0
1
0
0001875411
Sloss Dakin
C/O PRIME MOVERS LAB FUND I LP
P.O. BOX 12829
JACKSON
WY
83002
0
0
1
0
Class A common stock
2021-11-15
4
C
0
2294473
A
2294473
I
Held by COVAXX PML SPV 1 LP
Class A common stock
2021-11-15
4
C
0
861857
A
861857
I
Held by COVAXX PML SPV 2 LP
Class A common stock
2021-11-15
4
C
0
1517754
A
1517754
I
Held by COVAXX PML SPV 3 LP
Class A common stock
2021-11-15
4
C
0
3615038
A
3615038
I
Held by Prime Movers Growth Fund 1 LP
Class A common stock
2021-11-15
4
C
0
9738192
A
9738192
D
Series A preferred stock
2021-11-15
4
C
0
3570201
D
Class A common stock
2294473
0
I
Held by COVAXX PML SPV 1 LP
Series A preferred stock
2021-11-15
4
C
0
1341050
D
Class A common stock
861857
0
I
Held by COVAXX PML SPV 2 LP
Series A preferred stock
2021-11-15
4
C
0
2361626
D
Class A common stock
1517754
0
I
Held by COVAXX PML SPV 3 LP
Series B preferred stock
2021-11-15
4
C
0
5625000
D
Class A common stock
3615038
0
I
Held by Prime Movers Growth Fund 1 LP
Series A preferred stock
2021-11-15
4
C
0
15152627
D
Class A common stock
9738192
0
D
Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock.
Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1.
Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2.
Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3.
Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG.
Held by PML. PML GP I is the general partner of PML.
Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.
Prime Movers Lab Fund I LP /s/ Jon Layman, Authorized Person
2021-11-15
Dakin Sloss /s/ Jon Layman, Attorney-in-fact
2021-11-15